These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
408 related articles for article (PubMed ID: 26752643)
1. Towards HIV-1 remission: potential roles for broadly neutralizing antibodies. Halper-Stromberg A; Nussenzweig MC J Clin Invest; 2016 Feb; 126(2):415-23. PubMed ID: 26752643 [TBL] [Abstract][Full Text] [Related]
2. Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies. Zhang Z; Li S; Gu Y; Xia N Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869733 [TBL] [Abstract][Full Text] [Related]
3. New-Generation High-Potency and Designer Antibodies: Role in HIV-1 Treatment. Gama L; Koup RA Annu Rev Med; 2018 Jan; 69():409-419. PubMed ID: 29029583 [TBL] [Abstract][Full Text] [Related]
4. Broadly neutralizing antibody and the HIV reservoir in acute HIV infection: a strategy toward HIV remission? Ananworanich J; McSteen B; Robb ML Curr Opin HIV AIDS; 2015 May; 10(3):198-206. PubMed ID: 25700203 [TBL] [Abstract][Full Text] [Related]
5. The Use of Broadly Neutralizing Antibodies (bNAbs) in HIV-1 Treatment and Prevention. Thavarajah JJ; Hønge BL; Wejse CM Viruses; 2024 Jun; 16(6):. PubMed ID: 38932203 [TBL] [Abstract][Full Text] [Related]
6. Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies. Parsons MS; Chung AW; Kent SJ Retrovirology; 2018 Aug; 15(1):58. PubMed ID: 30134945 [TBL] [Abstract][Full Text] [Related]
7. Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic. Caskey M; Klein F; Nussenzweig MC Nat Med; 2019 Apr; 25(4):547-553. PubMed ID: 30936546 [TBL] [Abstract][Full Text] [Related]
8. Antibody B cell responses in HIV-1 infection. Mouquet H Trends Immunol; 2014 Nov; 35(11):549-61. PubMed ID: 25240985 [TBL] [Abstract][Full Text] [Related]
9. Broadly neutralizing antibodies for treatment and prevention of HIV-1 infection. Cohen YZ; Caskey M Curr Opin HIV AIDS; 2018 Jul; 13(4):366-373. PubMed ID: 29697469 [TBL] [Abstract][Full Text] [Related]
10. Broadly Neutralizing Antibodies: Magic Bullets against HIV? Julg B; Alter G Immunity; 2016 Jun; 44(6):1253-4. PubMed ID: 27332729 [TBL] [Abstract][Full Text] [Related]
11. Adeno-associated virus gene delivery of broadly neutralizing antibodies as prevention and therapy against HIV-1. Lin A; Balazs AB Retrovirology; 2018 Oct; 15(1):66. PubMed ID: 30285769 [TBL] [Abstract][Full Text] [Related]
12. Utilizing immunotherapy towards achieving a functional cure for HIV-1. Sugiyama FHC; Dietz LL; Søgaard OS Curr Opin HIV AIDS; 2024 Jul; 19(4):187-193. PubMed ID: 38686856 [TBL] [Abstract][Full Text] [Related]
13. Engineering broadly neutralizing antibodies for HIV prevention and therapy. Hua CK; Ackerman ME Adv Drug Deliv Rev; 2016 Aug; 103():157-173. PubMed ID: 26827912 [TBL] [Abstract][Full Text] [Related]
14. Of Mice, Macaques, and Men: Broadly Neutralizing Antibody Immunotherapy for HIV-1. Nishimura Y; Martin MA Cell Host Microbe; 2017 Aug; 22(2):207-216. PubMed ID: 28799906 [TBL] [Abstract][Full Text] [Related]
15. In vivo protection by broadly neutralizing HIV antibodies. van Gils MJ; Sanders RW Trends Microbiol; 2014 Oct; 22(10):550-1. PubMed ID: 25169020 [TBL] [Abstract][Full Text] [Related]
16. Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review. Mahomed S; Garrett N; Baxter C; Abdool Karim Q; Abdool Karim SS J Infect Dis; 2021 Feb; 223(3):370-380. PubMed ID: 32604408 [TBL] [Abstract][Full Text] [Related]